Literature DB >> 24024124

Fgf signaling in adipocytes as a target for metabolic diseases.

Hiroya Ohta1, Nobuyuki Itoh.   

Abstract

Entities:  

Year:  2012        PMID： 24024124      PMCID： PMC3757662          DOI： 10.1016/j.molmet.2012.11.004

Source DB:  PubMed          Journal:  Mol Metab        ISSN： 2212-8778            Impact factor:   7.422


× No keyword cloud information.
  10 in total

1.  The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue.

Authors:  Andrew C Adams; Chaofeng Yang; Tamer Coskun; Christine C Cheng; Ruth E Gimeno; Yongde Luo; Alexei Kharitonenkov
Journal:  Mol Metab       Date:  2012-08-28       Impact factor: 7.422

2.  The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

Authors:  Alexei Kharitonenkov; Victor J Wroblewski; Anja Koester; Yun-Fei Chen; Cathleen K Clutinger; Xenia T Tigno; Barbara C Hansen; Armen B Shanafelt; Garret J Etgen
Journal:  Endocrinology       Date:  2006-10-26       Impact factor: 4.736

3.  FGF-21 as a novel metabolic regulator.

Authors:  Alexei Kharitonenkov; Tatiyana L Shiyanova; Anja Koester; Amy M Ford; Radmila Micanovic; Elizabeth J Galbreath; George E Sandusky; Lisa J Hammond; Julie S Moyers; Rebecca A Owens; Jesper Gromada; Joseph T Brozinick; Eric D Hawkins; Victor J Wroblewski; De-Shan Li; Farrokh Mehrbod; S Richard Jaskunas; Armen B Shanafelt
Journal:  J Clin Invest       Date:  2005-05-02       Impact factor: 14.808

Review 4.  Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.

Authors:  Nobuyuki Itoh
Journal:  Cell Tissue Res       Date:  2010-08-24       Impact factor: 5.249

5.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.

Authors:  Takeshi Inagaki; Paul Dutchak; Guixiang Zhao; Xunshan Ding; Laurent Gautron; Vinay Parameswara; Yong Li; Regina Goetz; Moosa Mohammadi; Victoria Esser; Joel K Elmquist; Robert D Gerard; Shawn C Burgess; Robert E Hammer; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

6.  Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.

Authors:  Yuhei Hotta; Hirotoshi Nakamura; Morichika Konishi; Yusuke Murata; Hiroyuki Takagi; Shigenobu Matsumura; Kazuo Inoue; Tohru Fushiki; Nobuyuki Itoh
Journal:  Endocrinology       Date:  2009-07-09       Impact factor: 4.736

7.  Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys.

Authors:  Murielle M Véniant; Renee Komorowski; Ping Chen; Shanaka Stanislaus; Katherine Winters; Todd Hager; Lei Zhou; Russell Wada; Randy Hecht; Jing Xu
Journal:  Endocrinology       Date:  2012-07-13       Impact factor: 4.736

8.  A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis.

Authors:  Johan W Jonker; Jae Myoung Suh; Annette R Atkins; Maryam Ahmadian; Pingping Li; Jamie Whyte; Mingxiao He; Henry Juguilon; Yun-Qiang Yin; Colin T Phillips; Ruth T Yu; Jerrold M Olefsky; Robert R Henry; Michael Downes; Ronald M Evans
Journal:  Nature       Date:  2012-05-17       Impact factor: 49.962

9.  Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress.

Authors:  Chaofeng Yang; Cong Wang; Min Ye; Chengliu Jin; Weimin He; Fen Wang; Wallace L McKeehan; Yongde Luo
Journal:  Nutr Metab (Lond)       Date:  2012-10-30       Impact factor: 4.169

10.  FGF21 promotes metabolic homeostasis via white adipose and leptin in mice.

Authors:  Murielle M Véniant; Clarence Hale; Joan Helmering; Michelle M Chen; Shanaka Stanislaus; Jim Busby; Steven Vonderfecht; Jing Xu; David J Lloyd
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240
  10 in total
  1 in total

Review 1.  Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets.

Authors:  Yadan Chen; Haiming Ma; Dasheng Zhu; Guowei Zhao; Lili Wang; Xiujuan Fu; Wei Chen
Journal:  PPAR Res       Date:  2017-06-04       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.